American Renal Associates Holdings Revenue, Profits - ARA Quarterly Income Statement

Add to My Stocks
$15.88 $0.17 (1.08%) ARA stock closing price Jul 20, 2018 (Closing)

Financial analysis of American Renal Associates Holdings involves more than just checking the American Renal Associates Holdings stock price, by looking at the financial statements of the company in detail. In the income statement, an investor can look at important parameters like revenue or sales, gross profits, net profits, and EPS basic to gain deeper insights. Like any other income statement, the ARA income statement also itemizes revenue/sales, operating expenses, and profits/bottomline for a quarter or year and reflects a QoQ revenue growth of 0.15% when compared to the same period in the past. Along with American Renal Associates Holdings assets and American Renal Associates Holdings free cash flow, American Renal Associates Holdings profits as shown in profit and loss statement give key insights about the business. The net profit for 2018 Q1 is $-0.33M and the 2018 Q1 revenue is $194.67M.

View and download details of revenue and profits for American Renal Associates Holdings for latest & last 40 quarters.
show more
Quarterly
Annual
View Previous Quarters
View Next Quarters
Fiscal year is Jan - Dec2018 Q12017 Q42017 Q32017 Q22017 Q12016 Q42016 Q32016 Q22016 Q12015 Q4
American Renal Associates Holdings Revenues or Net Sales
194.67M194.38M187.71M185.99M177.03M199.11M192.96M186.94M172.13M174.22M
Cost Of Goods Sold (COGS)133.73M124.51M119.59M118.05M120.3M121.17M116.11M109.71M105.45M102.6M
American Renal Associates Holdings Gross Profit
60.94M69.89M68.11M67.93M56.72M77.96M76.84M75.84M66.67M71.62M
Research & Development Expense----------
Selling General & Admin Expense29.91M26.22M25.77M31.39M35.18M43.86M37.4M33.86M21.52M20.58M
Income Before Depreciation Depletion Amortization31.02M43.69M42.33M36.53M21.54M34.1M39.43M41.98M45.15M51.04M
Depreciation Depletion Amortization9.62M9.75M9.43M9.38M9.07M9.26M8.68M8.25M7.67M9M
Non Operating Income-1.02M1.77M3.58M-3.16M4.51M-3.44M12.56M-12.54M--
Interest Expense7.45M7.25M7.25M7.18M7.6M7.37M7.37M8.94M12.25M10.77M
American Renal Associates Holdings Pretax Income
12.92M28.47M29.23M16.8M9.37M14.06M35.94M12.24M25.21M31.29M
Provision for Income Taxes-0.79M8.75M2.55M--3.52M-2.17M-0.1M-1.14M2.66M3.57M
MinorityInterest14.62M19.5M18.68M18.49M14.15M23.69M23.62M22.48M18.8M20.89M
Investment Gains Losses----------
Other Income----------
Income Before Extraordinaries & Disc Operations-0.33M1.56M7.98M-4.63M-12.33M-7.12M12.42M-9.09M3.76M27.72M
Extraordinary Items & Discontinued Operations----------
American Renal Associates Holdings Profit/ Loss (Net Income)
-0.33M1.56M7.98M-4.63M-12.33M-7.12M12.42M-9.09M3.76M6.85M
Average Shares used to compute Diluted EPS31.8M34.02M33.83M30.99M30.91M30.89M31.44M28.41M22.79M-
Average Shares used to compute Basic EPS31.8M31.56M31.1M30.99M30.91M30.89M30.87M28.41M22.21M-
Income Before Nonrecurring Items3.78M5.98M6.44M5.56M1.87M8.74M9.35M8.3M3.76M-
Income from Nonrecurring Items-4.11M-4.42M1.55M-10.19M-14.2M-15.86M3.07M-17.39M--
American Renal Associates Holdings Earnings Per Share Basic Net
-0.010.050.26-0.15-0.40-0.020.35-0.750.17-
American Renal Associates Holdings Earnings Per Share Diluted Net
-0.010.050.24-0.15-0.40-0.020.34-0.750.16-
EPS Diluted Before Nonrecurring Items0.110.180.190.160.060.260.280.260.16-
Preferred Dividends Acc Pd----------
Dividends Common0.000.00--------
Dividend Per Share Common0.000.000.000.000.000.000.000.000.000.00
All figures in USD. M: Millions of USD, B: Billions of USD.
View Previous Quarters
View Next Quarters

The key things to look for in an income statement while doing American Renal Associates Holdings stock analysis are:

  • Revenue: This is the inflow that is generated from the sale of goods or services and is $194.67M for this quarter of 2018 Q1. Our American Renal Associates Holdings revenue chart gives a clear visual representation of how the topline or sales growth has been. Investors often invest only in those companies where the revenue is growing at a steady rate.
  • Bottom line: This refers to the last line in a profit and loss statement and denotes the net profit or loss for a particular period. The figure currently stands at $-0.33M for American Renal Associates Holdings for 2018 Q1. This figure is arrived at after deducting all operating expenses, interest, and taxes from revenue.

The income statement is also called statement of revenue and expense. The ARA financials along with American Renal Associates Holdings historical stock prices provide a lot of details about the firm.

American Renal Associates Holdings Income Statement - Key Financial Ratios

PE Ratio (price earnings ratio)
122.15
PS Ratio (price sales ratio)
0.66
Operating Margin
11
Dividend Yield
0%

Other Income Statements - American Renal Associates Holdings Inc Industry Peers

AAC Holdings income statement, Addus HomeCare income statement, BioScrip income statement, HANGER INC income statement